Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward.
Van Deun A, Decroo T, Tahseen S, Trébucq A, Schwoebel V, Ortuno-Gutierrez N, de Jong BC, Rieder HL, Piubello A, Chiang CY. Van Deun A, et al. Among authors: tahseen s. Int J Antimicrob Agents. 2020 Jan;55(1):105822. doi: 10.1016/j.ijantimicag.2019.10.003. Epub 2019 Oct 15. Int J Antimicrob Agents. 2020. PMID: 31626907
Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.
Driesen M, Kondo Y, de Jong BC, Torrea G, Asnong S, Desmaretz C, Mostofa KSM, Tahseen S, Whitfield MG, Cirillo DM, Miotto P, Cabibbe AM, Rigouts L. Driesen M, et al. Among authors: tahseen s. Clin Microbiol Infect. 2018 Jan;24(1):60-64. doi: 10.1016/j.cmi.2017.05.026. Epub 2017 Jun 3. Clin Microbiol Infect. 2018. PMID: 28587904 Free PMC article.
Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis.
Rancoita PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, Hoosdally SJ, Walker TM, Grazian C, Davies TJ, Peto TEA, Crook DW, Fowler PW, Cirillo DM; CRyPTIC Consortiumfor the CRyPTIC Consortiumfor the CRyPTIC Consortium. Rancoita PMV, et al. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00344-18. doi: 10.1128/AAC.00344-18. Print 2018 Sep. Antimicrob Agents Chemother. 2018. PMID: 29941636 Free PMC article.
Sputum smear microscopy in the Xpert® MTB/RIF era.
Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL. Van Deun A, et al. Among authors: tahseen s. Int J Tuberc Lung Dis. 2019 Jan 1;23(1):12-18. doi: 10.5588/ijtld.18.0553. Epub 2018 Dec 19. Int J Tuberc Lung Dis. 2019. PMID: 30567624
In reply: A human rights-based approach to tuberculosis diagnosis.
Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL. Van Deun A, et al. Among authors: tahseen s. Int J Tuberc Lung Dis. 2019 Aug 1;23(8):959-960. doi: 10.5588/ijtld.18.0133. Int J Tuberc Lung Dis. 2019. PMID: 31533887 No abstract available.
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown.
Van Deun A, Decroo T, Aung KJM, Hossain MA, Gumusboga M, De Rijk WB, Tahseen S, de Jong BC, Rigouts L. Van Deun A, et al. Among authors: tahseen s. Eur Respir J. 2021 Sep 2;58(3):2100783. doi: 10.1183/13993003.00783-2021. Print 2021 Sep. Eur Respir J. 2021. PMID: 33926970 Free article. No abstract available.
68 results